Literature DB >> 24122017

Hypertrophic olivary degeneration with gadolinium enhancement after posterior fossa surgery in a child with medulloblastoma.

Johannes Nowak, Balint Alkonyi, Stefan Rutkowski, György A Homola, Monika Warmuth-Metz.   

Abstract

Hypertrophic olivary degeneration (HOD) is a rare transsynaptic form of degeneration occurring secondary to the disruption of the dentato-rubro-olivary pathway ("Guillain-Mollaret triangle"). HOD can be caused by ischemic, hemorrhagic, traumatic, or neoplastic lesions, and it can also occur following posterior fossa surgery. MRI characteristics of HOD include T2 signal increase and hypertrophy. To date, blood–brain barrier disruption has not been reported in HOD. Here, we present the first case of HOD with temporary gadolinium enhancement in a 10-year-old child 7 months after resection of a posterior fossa medulloblastoma. The recognition of gadolinium enhancement as a radiological feature of HOD may help to distinguish between this benign secondary condition and tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24122017     DOI: 10.1007/s00381-013-2296-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

1.  Diffusion tensor imaging of Guillain-Mollaret triangle in patients with hypertrophic olivary degeneration.

Authors:  Alp Dinçer; Onur Özyurt; Dilaver Kaya; Elif Koşak; Cengizhan Öztürk; Canan Erzen; M Necmettin Pamir
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

2.  Hypertrophic olivary degeneration secondary to a Guillain-Mollaret triangle lesion.

Authors:  J Sánchez Hernández; J C Paniagua Escudero; P Carreño Morán; J F Asensio Calle
Journal:  Neurologia       Date:  2011-07-02       Impact factor: 3.109

3.  Olivary enlargement: chronological and morphometric analyses.

Authors:  N Goto; M Kaneko
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 4.  Hypertrophic olivary degeneration in children: four new cases and a review of the literature with an emphasis on the MRI findings.

Authors:  S E Sanverdi; K K Oguz; G Haliloglu
Journal:  Br J Radiol       Date:  2012-02-14       Impact factor: 3.039

5.  Olivary degeneration after intracranial haemorrhage or trauma: follow-up MRI.

Authors:  M Suzuki; T Takashima; F Ueda; Y Fujinaga; Y Horichi; J Yamashita
Journal:  Neuroradiology       Date:  1999-01       Impact factor: 2.804

6.  Olivary degeneration after cerebellar or brain stem haemorrhage: MRI.

Authors:  A Uchino; K Hasuo; K Uchida; S Matsumoto; Y Tsukamoto; M Ohno; K Masuda
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

7.  Hypertrophic olivary degeneration after surgical resection of brain tumors.

Authors:  Yuki Shinohara; Toshibumi Kinoshita; Fumiko Kinoshita; Toshio Kaminou; Takashi Watanabe; Toshihide Ogawa
Journal:  Acta Radiol       Date:  2013-04-30       Impact factor: 1.990

8.  Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps.

Authors:  Jung Im Seok; Hanseung Yi; Young Min Song; Won Yong Lee
Journal:  Arch Neurol       Date:  2003-12

9.  Hypertrophic olivary degeneration following pontine haemorrhage: hypertensive crisis or cavernous haemangioma bleeding?

Authors:  T Krings; H Foltys; I G Meister; J Reul
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

10.  Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.

Authors:  Carsten Friedrich; André O von Bueren; Katja von Hoff; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Peter Hau; Frank Deinlein; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Eur J Cancer       Date:  2012-11-19       Impact factor: 9.162

View more
  2 in total

1.  MRI findings of olivary degeneration after surgery for posterior fossa tumours in children: incidence, time course and correlation with tumour grading.

Authors:  Tommaso Tartaglione; Giana Izzo; Andrea Alexandre; Annibale Botto; Giuseppe Maria Di Lella; Simona Gaudino; Massimo Caldarelli; Cesare Colosimo
Journal:  Radiol Med       Date:  2015-01-09       Impact factor: 3.469

2.  Mutations in TTC19: expanding the molecular, clinical and biochemical phenotype.

Authors:  Johannes Koch; Peter Freisinger; René G Feichtinger; Franz A Zimmermann; Christian Rauscher; Hans P Wagentristl; Vassiliki Konstantopoulou; Rainer Seidl; Tobias B Haack; Holger Prokisch; Uwe Ahting; Wolfgang Sperl; Johannes A Mayr; Esther M Maier
Journal:  Orphanet J Rare Dis       Date:  2015-04-02       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.